This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1999.
Company Filing History:
1 out of 834,307 Years Active: 1999
Title: Urmas Arumae: Innovator in Kidney Morphogenesis
Introduction
Urmas Arumae is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of kidney morphogenesis through his innovative research and patents. His work focuses on the regulation of glial cell line-derived neurotrophic factor (GDNF) and its effects on ureteric development.
Latest Patents
Urmas Arumae holds a patent titled "Glial cell line-derived neurotrophic factor regulation of ureteric." This patent discloses the effects of GDNF on kidney morphogenesis. It includes methods for stimulating budding and branching of the ureteric epithelium, promoting axonal outgrowth, maintaining ureteric epithelial cells in culture, preventing apoptosis of these cells, and treating diseases using GDNF. He has 1 patent to his name.
Career Highlights
Throughout his career, Urmas Arumae has focused on the intersection of neurobiology and kidney development. His research has provided valuable insights into how GDNF can influence kidney formation and function. His innovative approaches have opened new avenues for therapeutic interventions in kidney-related diseases.
Collaborations
Urmas has collaborated with esteemed colleagues such as Hannu Sariola and Mart Saarma. These partnerships have enhanced the depth and impact of his research, contributing to advancements in the understanding of kidney morphogenesis.
Conclusion
Urmas Arumae is a pioneering inventor whose work on GDNF and kidney morphogenesis has the potential to transform therapeutic strategies for kidney diseases. His contributions to science and innovation continue to inspire future research in this critical area.